Flat-design illustration of an Australian residential aged care home, a faceless on-site pharmacist, medication capsules and a checked medication chart, with the text On-Site Pharmacist and Aged Care 2026.

From 1 July 2026, every pharmacist participating in the Australian Government's Aged Care On-Site Pharmacist (ACOP) measure must have completed an Australian Pharmacy Council-accredited ACOP training program. The transitional route that allowed an existing Medication Management Review credential plus a commitment to complete the additional training by 30 June has ended. For participating residential aged care homes, that turns a professional-development deadline into an immediate credential, rostering and claiming control.

The Department of Health, Disability and Ageing updated the ACOP program page on 2 July 2026 and published a detailed pharmacist and residential aged care home guide for the 2026-27 financial year. The guide confirms funding of one full-time equivalent pharmacist per 250 beds, scaled in 50-bed bands. It also requires an ACOP weekly timesheet and activities summary to support claims, and it gives homes that engage a pharmacist directly a seven-year record-retention obligation.

This is a distinct compliance workflow from ordinary medication-management policy. The right person must hold the right credential before they participate, the home must choose the correct engagement pathway, on-site time must match the funded band, and each claim must be backed by signed operational evidence. This guide turns those requirements into a practical checklist for facility managers, clinical governance leads and provider compliance teams.

What changed in the aged care on-site pharmacist rules on 1 July 2026?

The ACOP measure has operated since 1 July 2024. During the transition, a pharmacist could participate if they had completed an APC-accredited ACOP program or held an existing Medication Management Review credential and committed to completing an approved ACOP program or recognition-of-prior-learning process by 30 June 2026. That grace period is over.

The current federal rule is direct: a pharmacist participating in the measure must be registered with a valid Australian Health Practitioner Regulation Agency number and must be ACOP credentialed through completion of an APC-accredited ACOP training program. APC's register listed eight accredited or accredited-with-conditions MMR/ACOP programs as at 27 February 2026. Providers should check the live APC register rather than relying on a course title, training invoice or an older MMR certificate.

Do not treat a current AHPRA registration or an MMR credential by itself as evidence that a pharmacist can participate in ACOP after 1 July 2026. Your file should show both current pharmacist registration and completion of an APC-accredited ACOP program.

The Department's guide also recognises that a residential aged care home may impose additional induction requirements before a credentialed pharmacist starts. These may include professional indemnity insurance, police checks, an NDIS Worker Screening Check, vaccination history and home-specific mandatory training. Those controls sit alongside the federal ACOP credential; they do not replace it.

How the 2026-27 ACOP funding bands work

The measure funds one ACOP full-time equivalent for every 250 beds. Funding is divided into 50-bed bands so even a small eligible home can have a regular on-site presence. The 2026-27 guide sets the following maximum annual amounts, excluding GST:

  • 1 to 50 beds: 0.2 FTE, up to 1 on-site day a week and $28,991.69 a year.
  • 51 to 100 beds: 0.4 FTE, up to 2 on-site days a week and $57,983.38 a year.
  • 101 to 150 beds: 0.6 FTE, up to 3 on-site days a week and $86,975.07 a year.
  • 151 to 200 beds: 0.8 FTE, up to 4 on-site days a week and $115,966.76 a year.
  • 201 to 250 beds: 1.0 FTE, up to 5 on-site days a week and $145,277.04 a year.
  • 251 to 300 beds: 1.2 FTE, up to 6 on-site days a week and $174,268.73 a year.
  • 301 or more beds: 1.4 FTE, up to 7 on-site days a week and $203,260.42 a year.

The worked example in the federal guide matters for rostering: a 61-bed home falls into the 51-to-100-bed band and is funded for two full days a week, or 0.4 FTE. The pharmacist must work at the home on a regular schedule agreed with the home, in minimum blocks of half a day (3.8 hours). Homes in Modified Monash Model categories 5 to 7 can use extended flexible arrangements, such as condensing several funded days into one block.

The funded amount is a ceiling, not an automatic entitlement to claim every available day. If a home chooses three days when its band allows five, only the three worked days can be claimed. The 2026-27 guide also caps days across the full financial year so monthly maximums cannot be used to exceed the annual entitlement. That makes a live bed-band calculation, schedule and year-to-date claim counter essential.

Choose the right engagement and claiming pathway

There are two pathways for accessing a credentialed on-site pharmacist. Under Tier 1, a section 90 community pharmacy engages the ACOP and claims the funding. Under Tier 2, the residential aged care home engages the ACOP and claims directly, but this pathway is available only when the home has been unsuccessful in sourcing a credentialed pharmacist through the community pharmacy of its choice.

Primary Health Networks can help connect homes with eligible pharmacists and raise awareness of the measure, but they do not employ the ACOP. Document every contact with a community pharmacy and the reason Tier 1 could not proceed before moving to Tier 2. That evidence explains why the home was eligible to claim directly if the arrangement is reviewed later.

Participation also changes which medication-management services can be funded. A home that engages an on-site pharmacist under ACOP cannot also receive Quality Use of Medicines or Residential Medication Management Review program services from visiting pharmacists. Providers need a clear cut-over date and controls that prevent overlapping claims or duplicate service arrangements.

Before the first ACOP claim, record the bed band, pathway, maximum funded days, regular schedule and the date any RMMR or QUM arrangement ended. A correct pharmacist credential does not cure an incorrect claiming pathway.

The signed timesheet and seven-year evidence rule

The ACOP weekly timesheet and activities summary is mandatory. It must be completed by the pharmacist and signed by a residential aged care home representative. The record supports salary claiming and demonstrates that the pharmacist worked within the ACOP role and activity guidance.

For homes using Tier 2, the federal guide says each timesheet and activities summary must be kept for seven years after the claim for audit and compliance purposes. A basic roster or payroll report is not enough because the official control records both time and the work performed. The activities summary should connect the claim to clinical governance, medication review, staff education, transitions of care, policy improvement or other work inside the ACOP scope.

The signed summary is also a useful governance artefact. The guide expects the pharmacist and home to discuss completed activities, findings and future priorities. That creates a recurring evidence trail showing how the funded role is improving medication safety rather than operating as an isolated staffing line.

What the home must do before the pharmacist starts

The new July guide includes an orientation checklist that makes integration an explicit provider responsibility. A residential aged care home should identify the pharmacist's line manager, agree communication channels, set priority activities and provide access to the information systems needed to work safely.

  • Verify the pharmacist's AHPRA number and ACOP credential against current source records.
  • Complete local screening, insurance, vaccination and mandatory-training checks.
  • Give appropriate access to resident records, medication charts, My Health Record, email and a computer.
  • Introduce the pharmacist to residents, families, care staff, GPs, prescribers, specialists and the supply pharmacy.
  • Invite the pharmacist into case conferences, medication advisory meetings, falls and incident reviews, antimicrobial stewardship and clinical-governance forums.
  • Agree how observations and recommendations will be documented, assigned, closed and reported to the governing body.

The clinical role can include medication reconciliation after hospital discharge, audits of residents at risk of medication-related harm, review of medication rounds, staff education, vaccination support and improvements to medication policies. The value comes from continuity and integration. A pharmacist who has the credential but no access, no schedule and no governance channel cannot deliver the outcome the measure funds.

Why providers should act even though participation is voluntary

Participation in ACOP is voluntary, but the underlying medication-safety obligations are not. The Royal Commission identified medication management as an essential area for improvement, and the strengthened Aged Care Quality Standards require providers to manage clinical risks, support safe use of medicines and maintain competent workers and effective governance.

The federal year-one review found that just over 12% of eligible residential aged care homes had taken up an on-site pharmacist. Participation exceeded 35% in the ACT and was about 15% in NSW, the NT, Queensland, South Australia and Western Australia. Uptake was similar across the main home-size bands, which shows the 50-bed funding increments are designed to make the model usable beyond large metropolitan facilities.

The same review found that about 85% of participating homes sourced their pharmacist through a community pharmacy, with the remainder engaging directly. It also noted that participation requires an electronic National Residential Medication Chart or a commitment to introduce one within 12 months. Providers evaluating ACOP should therefore treat the decision as a combined workforce, digital-record and clinical-governance project.

A 30-day aged care on-site pharmacist compliance plan

Days 1 to 5 — establish scope. Confirm whether each home is eligible, its maximum bed capacity and its 2026-27 funding band. Record any existing QUM or RMMR arrangements and identify the cut-over implications.

Days 6 to 10 — verify people and pathway. Validate each proposed pharmacist's AHPRA registration and APC-accredited ACOP completion. Document Tier 1 pharmacy engagement attempts. If Tier 2 is needed, retain the evidence that the home could not secure a suitable Tier 1 arrangement.

Days 11 to 20 — build the operating file. Finalise the regular schedule, induction, screening, systems access and role priorities. Set up the weekly timesheet and activities summary with pharmacist and home sign-off. Configure a seven-year retention rule for Tier 2 claim evidence.

Days 21 to 30 — rehearse the first claim. Reconcile scheduled time to actual on-site time, confirm minimum 3.8-hour blocks, check the year-to-date funded-day cap, and verify the activities are within scope. Produce a mock evidence pack containing the credential, engagement pathway, bed-band calculation, schedule, signed summary and claim reconciliation.

Run the evidence pack from a cold start. A reviewer should be able to answer five questions without email archaeology: Is the pharmacist eligible? Why is this claiming pathway valid? What is the home's funded band? What work occurred? Who signed the claim evidence?

How NovoCove handles this

NovoCove links the pharmacist record to AHPRA registration, the ACOP certificate, insurance, screening, vaccination and facility-specific training. Expiry and review alerts sit alongside the regular on-site schedule, so a home can prevent an unverified person or an incomplete induction from entering the funded roster.

For claiming, NovoCove stores the bed-band calculation, Tier 1 or Tier 2 evidence, maximum funded days and every signed weekly timesheet and activities summary. A year-to-date control flags schedules or claims approaching the annual ceiling, while seven-year retention rules preserve the Tier 2 evidence without depending on staff inboxes.

At governance level, pharmacist activities can be linked to medication incidents, audits, corrective actions, training and policy reviews. That lets facility managers show both sides of the ACOP story: the funding claim is supported, and the pharmacist's work is improving medication safety. Book a demo to see how one evidence pack can connect the credential, schedule, claim and clinical-governance record for every home in your group.

Official sources

This guide is general information and is not legal advice.

Make every pharmacist credential and funding claim audit-ready

NovoCove tracks AHPRA registration, ACOP credentials, induction evidence, recurring schedules and signed claim records in one place. Build an evidence pack by home, pharmacist or claim period without rebuilding it from email and spreadsheets.

Book a demo